Most Read This Week
- Systematic TRUS Biopsy vs mMRI–Targeted Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer
- ASCO GU 2021: Talazoparib Demonstrates Durable Antitumor Activity in Metastatic Castration-Resistant Prostate Cancer
- Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
- ASCO GU 2021: Retroperitoneal Lymph Node Dissection Should Be Considered First-Line for Metastatic Seminoma
- Decipher Genomic Classifier in Prostate Cancer
Recently Updated
- Transurethral Ultrasound Ablation of Prostate Cancer
- Pessary Treatment Successful for Symptomatic Pelvic Organ Prolapse
- Time From eGFR Wait-List Threshold to ESKD Shorter in Blacks
- Cardiovascular Effects of GnRH Antagonists in Men With Prostate Cancer
- Lenvatinib Plus Pembrolizumab Tops Sunitinib in Advanced RCC